VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia
00013 HUTCHMED (China) LimitedHUTCHMEDHong Kong Stock Exchange
10 posts
HUTCHMED (China) Limited (00013) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
HUTCHMED (China) Limited (00013) Stock Price History
HUTCHMED (China) Limited closed at HK$23.86 on Nov 11, 2026, +9.8% over 1 month, +0.6% over 1 year.
If you had invested HK$10,000 1 month ago, it would be worth HK$11,191 today (+11.9%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +1.2%, while this stock moved +11.9%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | HK$23.86 | −0.42 | −1.73% |
| Nov 10 (Tue) | HK$24.28 | +0.22 | +0.91% |
| Nov 9 (Mon) | HK$24.06 | +0.90 | +3.89% |
| Nov 6 (Fri) | HK$23.16 | +0.24 | +1.05% |
| Nov 5 (Thu) | HK$22.92 | +1.04 | +4.75% |
| Nov 4 (Wed) | HK$21.88 | +1.32 | +6.42% |
| Nov 3 (Tue) | HK$20.56 | −0.16 | −0.77% |
| Nov 2 (Mon) | HK$20.72 | −0.06 | −0.29% |
| Oct 30 (Fri) | HK$20.78 | −0.38 | −1.80% |
| Oct 29 (Thu) | HK$21.16 | +0.06 | +0.28% |
If you had invested HK$10,000 3 months ago, it would be worth HK$12,124 today (+21.2%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −4.3%, while this stock moved +21.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | HK$23.86 | −0.42 | −1.73% |
| Nov 10 (Tue) | HK$24.28 | +0.22 | +0.91% |
| Nov 9 (Mon) | HK$24.06 | +0.90 | +3.89% |
| Nov 6 (Fri) | HK$23.16 | +0.24 | +1.05% |
| Nov 5 (Thu) | HK$22.92 | +1.04 | +4.75% |
| Nov 4 (Wed) | HK$21.88 | +1.32 | +6.42% |
| Nov 3 (Tue) | HK$20.56 | −0.16 | −0.77% |
| Nov 2 (Mon) | HK$20.72 | −0.06 | −0.29% |
| Oct 30 (Fri) | HK$20.78 | −0.38 | −1.80% |
| Oct 29 (Thu) | HK$21.16 | +0.06 | +0.28% |
If you had invested HK$10,000 6 months ago, it would be worth HK$11,742 today (+17.4%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.0%, while this stock moved +17.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$23.86 | +14.8% |
| Oct 2026 | HK$20.78 | −9.7% |
| Sep 2026 | HK$23.00 | +18.7% |
| Aug 2026 | HK$19.37 | +9.4% |
| Jul 2026 | HK$17.71 | +5.5% |
| Jun 2026 | HK$16.78 | −8.4% |
| May 2026 | HK$18.32 | −13.3% |
If you had invested HK$10,000 1 year ago, it would be worth HK$10,059 today (+0.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.0%, while this stock moved +0.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$23.86 | +14.8% |
| Oct 2026 | HK$20.78 | −9.7% |
| Sep 2026 | HK$23.00 | +18.7% |
| Aug 2026 | HK$19.37 | +9.4% |
| Jul 2026 | HK$17.71 | +5.5% |
| Jun 2026 | HK$16.78 | −8.4% |
| May 2026 | HK$18.32 | −13.3% |
| Apr 2026 | HK$21.14 | −6.8% |
| Mar 2026 | HK$22.68 | −0.1% |
| Feb 2026 | HK$22.70 | −2.9% |
| Jan 2026 | HK$23.38 | +13.4% |
| Dec 2025 | HK$20.62 | −8.3% |
| Nov 2025 | HK$22.48 | −3.4% |
If you had invested HK$10,000 3 years ago, it would be worth HK$8,185 today (−18.1%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +40.7%, while this stock moved −18.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$23.86 | +15.7% |
| 2025 | HK$20.62 | ― |
If you had invested HK$10,000 5 years ago, it would be worth HK$4,930 today (−50.7%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −2.0%, while this stock moved −50.7%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$23.86 | +15.7% |
| 2025 | HK$20.62 | ― |
If you had invested HK$10,000 in Jun 2021, it would be worth HK$3,702 today (−63.0%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −5.1%, while this stock moved −63.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$23.86 | +13.9% |
| 2025 | HK$20.94 | −9.9% |
| 2024 | HK$23.25 | −19.0% |
| 2023 | HK$28.70 | +19.6% |
| 2022 | HK$24.00 | −57.5% |
| 2021 | HK$56.45 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2021). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS plus TAGRISSO in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
Delete
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia
Delete
VOLUNTARY ANNOUNCEMENT - Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer
Delete
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS plus TAGRISSO in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026
Delete
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
Delete
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Closing of KRAS-EGFR-Antibody Conjugate Therapy License to GSK Outside China
Delete
VOLUNTARY ANNOUNCEMENT - HUTCHMED Announces Submission of US NDA for ORPATHYS plus TAGRISSO in MET Driven EGFR-Mutated Lung Cancer
Delete
VOLUNTARY ANNOUNCEMENT - HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
Delete
VOLUNTARY ANNOUNCEMENT - HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026
Delete
Write on the HUTCHMED (China) Limited board
More Chinese stocks in English
- Hysan Development Company Limited00014
- New World Development Company Limited00017
- Oriental Media Group Limited00018
- Swire Pacific Limited A00019
- SenseTime Group Inc.00020
- Great China Holdings (Hong Kong) Limited00021
- Mexan Limited00022
- The Bank of East Asia Limited00023
- Chevalier International Holdings Ltd.00025
- China Motor Bus Co., Ltd.00026
- Tian An China Investments Company Limited00028
- Dynamic Holdings Ltd.00029